Display options
Cite
Nosratnejad S, Barfar E, Hosseini H, et al. Cost-effectiveness of Anemia Screening in Vulnerable Groups: A Systematic Review. Int J Prev Med. 2014;5(7):813-9
Nosratnejad, S., Barfar, E., Hosseini, H., Barooti, E., & Rashidian, A. (2014). Cost-effectiveness of Anemia Screening in Vulnerable Groups: A Systematic Review. International journal of preventive medicine, 5(7), 813-9.
Nosratnejad, Shirin, et al. "Cost-effectiveness of Anemia Screening in Vulnerable Groups: A Systematic Review." International journal of preventive medicine vol. 5,7 (2014): 813-9.
Nosratnejad S, Barfar E, Hosseini H, Barooti E, Rashidian A. Cost-effectiveness of Anemia Screening in Vulnerable Groups: A Systematic Review. Int J Prev Med. 2014 Jul;5(7):813-9. PMID: 25104991; PMCID: PMC4124557.
Copy Download .nbib Format: NLM
Share it on

Int J Prev Med. 2014 Jul;5(7):813-9.

Cost-effectiveness of Anemia Screening in Vulnerable Groups: A Systematic Review.

International journal of preventive medicine

Shirin Nosratnejad, Eshagh Barfar, Hamed Hosseini, Esmat Barooti, Arash Rashidian

Affiliations

  1. Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  2. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
  3. Women's Affairs Office, Ministry of Health and Medical Education, Tehran, Iran.
  4. Department of Health Management and Economics, School of Public Health and Knowledge Utilization Research Center, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 25104991 PMCID: PMC4124557

Abstract

BACKGROUND: Anemia is the most common blood disorder observed in vulnerable groups and affects their efficiency in their everyday activities. Possible complications of the disease may be reduced or prevented by screening of patients. Screening programs impose certain costs upon the health system, which may offset their positive effects. Whether the positive impacts of screening outweigh its costs is a subject of debate among policy-makers. In this research, we have conducted a systematic review of the cost-effectiveness of anemia screening.

METHODS: The Pubmed, Science Direct, SCOPUS, EMBASE, and CINAHL databases were searched for relevant results dating between 1962-2010 using key words. The references of the related articles were gone over manually. In the end, Persian databases were also examined for results.

RESULTS: Using data from the four mentioned databases, a total of 722 articles were elected, which, after evaluation, were narrowed down to 4. Of these, 3 focused on newborns and infants. Disparity existed among obtained results, such that no two articles were similar, and this made making comparisons between them cumbersome and sometimes even impossible. Only one study evaluated cost-effectiveness of anemia screening in vulnerable target groups.

CONCLUSIONS: Research findings show that there is not enough evidence of cost-effectiveness of screening for decision-making. Bearing in mind the importance of the matter to health policy-makers, due to high prevalence of iron-deficiency anemia in low- and middle-income countries, conduction of research in this field seems necessary.

Keywords: Anemia; cost-effectiveness; screening; systematic review

References

  1. J Pediatr. 2000 Feb;136(2):201-8 - PubMed
  2. Am J Kidney Dis. 1997 May;29(5):651-7 - PubMed
  3. Early Hum Dev. 1996 Jul 19;45(3):257-75 - PubMed
  4. Asia Pac J Public Health. 2008;20(4):347-59 - PubMed
  5. J Pediatr. 2009 Jan;154(1):44-9 - PubMed
  6. Crit Rev Oncol Hematol. 2006 May;58(2):156-65 - PubMed

Publication Types